Rapid DPYD & UGT1A1 Testing to Help Reduce Chemotoxicity
Identify patients at increased risk of severe chemotherapy toxicity from fluoropyrimidines and irinotecan before treatment begins. Start fast, treat confidently.
ToxNav® AdvantageTM includes:
- Industry-best 48-hour turnaround time
- Coverage of all AMP Tier 1 and Tier 2 DPYD variants
- Broader variant coverage for diverse patient populations
- UGT1A1 testing to help guide irinotecan dosing
- Results aligned with FDA labeling and NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®)
- Powered by proven Oxford Cancer Biomarkers science
Comprehensive PGx for Reduced Trial and Error
More confident prescribing across the medications clinicians use most often. Find the right medication sooner with your patients’ unique DNA and our 48-hour turnaround time.
Mira Comprehensive PGx helps guide prescribing in:
- Mental health medications: ADHD, anxiety, depression, and mood disorders
- Everyday wellness: Heart health, cholesterol, gastric reflux, and diabetes
- Pain management: Chronic pain, nerve pain, and even gout
- Specialized care: Cancer, autoimmune disorders, and organ transplants
- Infection and immunity: Fungal infections, HIV, and multiple sclerosis
- Results for 85+ commonly prescribed medications in 12 therapeutic areas
Setting the Standard: Unwavering Quality & Compliance
At Mira Precision Health, we prioritize the privacy and security of your genetic information. Our practices are fully compliant with HIPAA and HITECH regulations, ensuring the confidentiality and protection of your health data. We strictly adhere to the Genetic Information Nondiscrimination Act (GINA), safeguarding you against discrimination based on genetic information.
We are committed to maintaining the highest standards of data security, as evidenced by our HITRUST certification. Rest assured, we do not collect identifying genetic information, and any biological data we gather is shared exclusively with your healthcare provider. Your trust and privacy are paramount to us.
Streamlined Solutions for Personalized Patient Care
Mira Precision Health empowers providers with advanced decision support and a tailored EMR system. Our fast, Medicare-covered pharmacogenomic testing helps reduce patient costs while enabling safer, more effective treatments. Streamline care and enhance outcomes—without disrupting your workflow.
Empowering Healthcare Providers with Tailored
Pharmacogenomic Solutions
Serving Community Clinics, Healthcare Providers, and Long-Term Care Facilities.
Mira Precision Health Brings Precision Medicine to Every Patient.
Advanced Diagnostic Solutions for Precision Healthcare
Innovative Testing Services Tailored to Meet Diverse Clinical Needs
At Mira Precision Health, we provide healthcare providers with cutting-edge diagnostic solutions, including pharmacogenomic testing for precision medicine, in-vitro diagnostics, and serological testing for infectious diseases. Our advanced technologies empower clinicians to deliver precise care and enhance patient wellness. We also specialize in custom applications of clinical and research molecular diagnostics, partnering with experts across various biological disciplines.
Pharmacogenomics
Recognizing the challenges of low-quality DNA samples, Mira Precision Health utilizes a robust laboratory diagnostic platform designed to improve success rates with difficult samples. Our advanced clinical decision support software streamlines medication adjustments, ensuring optimal treatment outcomes. Additionally, we collaborate with partners to develop custom pharmacogenomic applications tailored to specific clinical and research needs.
In-Vitro Diagnostics
Mira Precision Health is a CLIA-certified, high-complexity clinical laboratory specializing in advanced nucleic acid analysis. Our team brings deep expertise in assay development, validation, and high-throughput molecular testing, supporting a wide range of clinical and research applications. We actively collaborate with laboratories, pharmaceutical partners, and clinical or R&D teams seeking to leverage our technical capabilities for innovative diagnostic programs and precision-medicine initiatives.